ArticleClinical pharmacology and therapeutics2026
Medication Use During Breastfeeding-An Understudied Population: A Five-Year Experience in the Pharmacovigilance Center of Lyon.
Article in Clinical pharmacology and therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medication use during breastfeeding is common, yet data on drug transfer into breast milk and infant exposure remain limited. This study describes real-world requests concerning medication compatibility with breastfeeding managed by the Lyon pharmacovigilance center over five years. We conducted a descriptive observational study including all requests recorded between January 2019 and December 2023. Characteristics of infants, medications involved, and recommendations provided were analyzed. A total of 2,473 requests were included, corresponding to approximately 500 per year. Most requests originated from patients (44%), allied health professionals (29%), or specialists (25%), with two thirds occurring postpartum. Overall, our recommendations supported breastfeeding in 87% of cases, either unconditionally or under specific conditions, such as clinical monitoring, therapeutic adjustments, or timing strategies. Only 13% of cases resulted in an unfavorable recommendation, for either treatment or breastfeeding discontinuation, due to formal contraindications, insufficient therapeutic benefit, or limited safety data. Polytherapy was observed in 35% of cases and was associated with more restrictive recommendations. Medications used for chronic conditions accounted for 36% of cases such as antihypertensives, antiepileptics, or psychotropic agents. Treatments for acute conditions included anti-infectives, analgesics, contrast agents, or anesthetics. Reported adverse effects in infants were rare and non-serious. In most cases, a recommendation supporting breastfeeding during maternal treatment, with or without conditions, was provided. However, uncertainty persists, particularly in complex or poorly documented situations. This work highlights the need for reliable, accessible information, inclusion of breastfeeding women in clinical research, and strengthened regulatory and postmarketing evaluation strategies to ensure infant safety health.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.